Two comparable models of BiOI/BiOCl heterojuctions with different interface structures (crystal surface orientation and crystal surface combination), denoted as BiOI(001)/BiOCl(001) and BiOI(001)/BiOCl(010), have been prepared via integrating heterojuncton nanostructure construction with crystal facet engineering. BiOI(001)/BiOCl(010) had a greater degree of lattice mismatch and displayed higher visible-light photocatalytic activity than BiOI(001)/BiOCl(001). In general, the activity of a photocatalyst (ηPC) has a positive correlation with light harvesting (ηLH), charge separation (ηCS), and charge injection (ηCI). On the basis of the experimental results, we considered that the higher ηCI value of BiOI(001)/BiOCl(010) was the main reason for its better visible-light photocatalytic performance. In combination with theoretical calculations, we found that the higher ηCI value of BiOI(001)/BiOCl(010) was the result of a shorter photogenerated electron diffusion distance, assisted by the self-induced internal electric fields of the BiOCl slabs. This indicated that the crystal facet combination is the key to enhancing the photocatalytic activity of BiOI/BiOCl. Our work offers an archetype for the further design of heterojunction photocatalysts with a fine tuning of the interface structures in order to reach optimized charge injection and enhanced photocatalytic activity.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: